DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (104)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 104   Next >>

Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Asthenia, Escherichia Infection, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Xanax; Benadryl; Metoprolol Tartrate; Vicodin; Protonix



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-22

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 300mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-26

Doxorubicin Hydrochloride
    Dosage: 29mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-26

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-04-26

Paclitaxel
    Dosage: 117mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-26

Trastuzumab
    Dosage: 456mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-04-26



Possible Paclitaxel side effects in 67 year old male

Reported by a consumer/non-health professional from Ireland on 2012-08-21

Patient: 67 year old male

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded: Ipilimumab
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Indication: non-Small Cell Lung Cancer

Paclitaxel
    Indication: non-Small Cell Lung Cancer

Placebo
    Indication: non-Small Cell Lung Cancer



Possible Paclitaxel side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: 30 year old female, weighing 106.6 kg (234.5 pounds)

Reactions: Vomiting, Blood Potassium Decreased, Nausea, Diarrhoea, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: carboauc5
    Indication: Endometrial Cancer
    Start date: 2012-08-06
    End date: 2012-08-06

Paclitaxel
    Dosage: taxol 175mg/m2
    Indication: Endometrial Cancer
    Start date: 2012-08-07
    End date: 2012-08-10

Ridaforolimus
    Dosage: ridaforolimus 20mg po qd
    Administration route: Oral
    Indication: Endometrial Cancer
    Start date: 2012-08-07
    End date: 2012-08-10



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Lovenox; Xanax; Benadryl; Duoneb; Protonix; Metoprolol; Vicodin



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Hypocalcaemia, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: drug used: non pegylated liposomal doxorubicin, last dose prior sae 30/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12

Herceptin
    Dosage: last dose prior to sae 21/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12

Herceptin
    Dosage: last dose prior to sae 21/may/2012, 366 mg

Lapatinib
    Dosage: last dose prior to sae :31/may/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-12

Paclitaxel
    Dosage: last dose prior to sae 30/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-07

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Diarrhoea, Pyrexia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-02-07

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-02-07

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-02-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-02-07

Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-02-07

Other drugs received by patient: Omeprazole



Possible Paclitaxel side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-02

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: White Blood Cell Count Decreased, Pyrexia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 15 mg
    Start date: 2012-07-10

Paclitaxel
    Dosage: 89 mg
    Start date: 2012-07-10



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Vicodin; Protonix; Lovenox; Duoneb; Metoprolol Tartrate; Xanax; Benadryl



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-27

Patient: female, weighing 92.0 kg (202.4 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-20

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-20

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-20

Trastuzumab
    Dosage: 8mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-06-19

Other drugs received by patient: Fenistil; Granisetron Hydrochloride; Ranitidine; Dexamethasone Sodium Phosphate



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Anaemia, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Acute Respiratory Distress Syndrome, Oedema, Hypoxia, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Metoprolol Tartrate; Xanax; Vicodin; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Thyranojod; Acetaminophen



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Diarrhoea, Pyrexia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-02-07

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-02-07

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-02-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-02-07

Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-02-07

Other drugs received by patient: Omeprazole



Possible Paclitaxel side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-18

Patient: 35 year old female

Reactions: Abdominal Pain, Vomiting, Nausea, Diarrhoea, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc5, in one hour, intravenous (not otherwise specified)
    Indication: Cervix Carcinoma

Cisplatin
    Dosage: 40 mg, weekly for 5 doses
    Indication: Cervix Carcinoma

Paclitaxel
    Dosage: 155 mg/m**2, over 3 hours
    Indication: Cervix Carcinoma

Other drugs received by patient: Sodium Chloride; Phenergan; Ranitidine; Serotonin (5ht3) Antagonists; Dexamethasone



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Hypoxia, Urosepsis, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Vicodin; Xanax; Metoprolol Tartrate; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: female, weighing 100.9 kg (222.0 pounds)

Reactions: Escherichia Test Positive, Dysuria, Rhinorrhoea, Culture Urine Positive, Pyrexia, Feeling Abnormal, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 6600 mg

Paclitaxel
    Dosage: 270 mg



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: female, weighing 100.9 kg (222.0 pounds)

Reactions: Productive Cough, Blood Pressure Increased, Wheezing, Cystitis Klebsiella, Oropharyngeal Pain, Pyrexia, Respiratory Tract Congestion, Myalgia, Fatigue, Dyspnoea Exertional, Activities of Daily Living Impaired, Impaired Healing

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
G-CSF (Filgrastim, Amgen)
    Dosage: 6 mg

Ifosfamide
    Dosage: 6600 mg

Paclitaxel
    Dosage: 270 mg



Possible Paclitaxel side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: male, weighing 104.0 kg (228.8 pounds)

Reactions: Dehydration, Pyrexia, Blood Sodium Decreased, Decreased Appetite, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 900 mg

Cetuximab (Erbitux) 537 MG
    Dosage: 537 mg

Paclitaxel
    Dosage: 462 mg



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: two doses held due to anc below 800 on 5/17/2012 and 6/1/2012

Paclitaxel
    Dosage: two doses held as anc below 800 on 5/17/2012 and 6/8/2012

Other drugs received by patient: Simvastatin; Ativan; Metformin Hydrochloride; Onglyza; Levothyroxine Sodium; Lisinopril



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Xanax; Metoprolol Tartrate; Vicodin; Benadryl; Protonix; Duoneb; Lovenox



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-11

Patient: female, weighing 92.0 kg (202.4 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-20

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-20

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-20

Trastuzumab
    Dosage: 8mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-06-19

Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Fenistil; Ranitidine



Possible Paclitaxel side effects in 67 year old female

Reported by a consumer/non-health professional from Ireland on 2012-07-05

Patient: 67 year old female

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded: Ipilimumab
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Placebo
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-10

Other drugs received by patient: Magnesium Oxide; Miralax; Multi-Vitamin; Omeprazole; Advair Diskus 100 / 50; Calcium Carbonate; Coumadin; Pristiq; Coumadin; Potassium Chloride; Spiriva; Tramadol HCL; Prednisone; Dexamethasone Sodium Phosphate; Diphenhydramine HCL; Proair HFA



Possible Paclitaxel side effects in 66 year old female

Reported by a physician from United States on 2012-07-02

Patient: 66 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Anaemia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: latest received date:08/mar/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-02-16

Carboplatin
    Dosage: latest received date: 22/may/2012
    Indication: Ovarian Epithelial Cancer

Paclitaxel
    Dosage: latest received date: 22/may/2012
    Indication: Ovarian Epithelial Cancer



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from Hong Kong on 2012-07-02

Patient: female, weighing 65.6 kg (144.3 pounds)

Reactions: Syncope, Pulmonary Tuberculosis, Urinary Tract Infection, Presyncope, Pyrexia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: form: infusion, last date prior to sae:02 aug 2011.
    Indication: Ovarian Cancer
    Start date: 2011-05-24
    End date: 2011-12-01

Carboplatin
    Dosage: last date prior to sae:02 aug 2011, dose 6 auc
    Indication: Ovarian Cancer
    Start date: 2011-05-24
    End date: 2011-12-01

Paclitaxel
    Dosage: form: infusion, last date prior to sae:02 aug 2011.
    Indication: Ovarian Cancer
    Start date: 2011-05-24
    End date: 2011-12-01

Other drugs received by patient: Lamivudine; Cimetidine; Diclofenac Sodium; Mefenamic Acid; Chloorhexidinedigluconaat; Maxolon; Levofloxacin; Neupogen; Generic Component(s) NOT Known; Gastrocaine; Filgrastim; Pepcidine



Possible Paclitaxel side effects in 74 year old female

Reported by a physician from Japan on 2012-06-29

Patient: 74 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Blood Bilirubin Increased, General Physical Condition Abnormal, Urinary Tract Infection, Nail Avulsion, Febrile Neutropenia, Pancytopenia, Pyrexia, Rash, Haematemesis, Hepatic Encephalopathy, Oedema Peripheral, Duodenal Ulcer Haemorrhage, Stevens-Johnson Syndrome, Cardiac Failure Congestive, Hepatitis Fulminant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Start date: 2010-04-27
    End date: 2010-04-27

Paclitaxel
    Start date: 2010-05-04
    End date: 2010-05-04

Paclitaxel
    Indication: Breast Cancer Stage II
    Start date: 2010-04-20
    End date: 2010-04-20

Taxotere
    Dosage: three [**] one [yasu]; cycles 1-11
    Indication: Breast Cancer Stage II
    Start date: 2010-06-10
    End date: 2010-09-08

Trastuzumab
    Dosage: dosage unknown and three [**] one [yasu]
    Indication: Breast Cancer Stage II
    Start date: 2010-04-20
    End date: 2010-05-11

Trastuzumab
    Start date: 2010-05-27

Other drugs received by patient: Zantac; Allegra; Allegra; Candesartan Cilexetil



Possible Paclitaxel side effects in female

Reported by a physician from France on 2012-06-04

Patient: female

Reactions: Pyrexia, Neutropenia, Radiation Mucositis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer
    Start date: 2012-02-24
    End date: 2012-02-24

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-02-24
    End date: 2012-02-24



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-05-24

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 260mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Doxorubicin HCL
    Dosage: 37mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: 520mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-04-30

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-04-30

Paclitaxel
    Dosage: 146mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Pantoprazole; Loperamide



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-05-23

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Herpes Simplex, General Physical Health Deterioration, Pyrexia, Cystitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc-2, last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30

Herceptin
    Dosage: last dose prior to sae 10 may 2012.
    Indication: Breast Cancer
    Start date: 2012-01-11

Lapatinib
    Dosage: permanently discontinued.
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-03-19

Paclitaxel
    Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-05-22

Patient: female

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-03-21

Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-03-21

Lapatinib
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-21

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-03-21

Trastuzumab
    Dosage: 6mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-03-21



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-05-17

Patient: female, weighing 76.0 kg (167.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Start date: 2012-05-08

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Start date: 2012-02-28
    End date: 2012-05-02

Herceptin
    Dosage: last dose prior to sae: 14 feb 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Herceptin
    Dosage: last dose prior to sae: 17 apr 2012
    Start date: 2012-02-28

Lapatinib
    Dosage: daily
    Start date: 2012-02-28
    End date: 2012-05-01

Lapatinib
    Dosage: last dose prior to sae: 20 feb 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Lapatinib
    Dosage: daily
    Start date: 2012-05-15

Paclitaxel
    Start date: 2012-05-08

Paclitaxel
    Start date: 2012-02-28
    End date: 2012-05-02

Paclitaxel
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017